What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?

Osteonecrosis of the jaw represents interference by external and internal factors in the natural bone remodeling system. Numerous bone remodeling agents (BMAs), such as bisphosphonates, denosumab, and tyrosine kinase inhibitors, can lead to medication-related osteonecrosis of the jaw (MRONJ). This i...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mihai Vlad Golu, Ionela Pașcanu, Cornelia Togănel, Cecilia Petrovan, Adina Cosarcă, Despina Luciana Bereczki Temistocle, Alina Ormenișan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2022-09-01
Serie:	Applied Sciences
Soggetti:	osteonecrosis of the jaw medication-related osteonecrosis of the jaw bisphosphonate-related osteonecrosis of the jaw dentistry oral health multidisciplinary approach
Accesso online:	https://www.mdpi.com/2076-3417/12/18/9224
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!